| 1397 |
National Cancer Institute |
Html |
en |
Lymphedema (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of lymphedema, a condition in which lymph fluid builds up in tissues and causes swelling. |
| cancer treatment | 0.423589 |
| PDQ cancer information | 0.483377 |
| lymph flow | 0.481362 |
| leg | 0.408261 |
| left lymph duct | 0.48735 |
| white blood cells | 0.398624 |
| secondary lymphedema | 0.507085 |
| clinical trials | 0.422847 |
| cancer information summary | 0.440651 |
| clinical trial | 0.38593 |
| tiny lymph vessels | 0.509598 |
| breast cancer patients | 0.459436 |
| sentinel lymph node | 0.518746 |
| certified lymphedema therapists | 0.498842 |
| breast cancer survivors | 0.394173 |
| upper-body exercise | 0.39564 |
| NCI PDQ cancer | 0.395621 |
| Untreated lymphedema | 0.491735 |
| lymph nodes | 0.686068 |
| swollen area | 0.380684 |
| radiation therapy | 0.378654 |
| treatment | 0.447311 |
| Lymphedema section | 0.47523 |
| lymphedema sleeves | 0.47753 |
| severe lymphedema | 0.470942 |
|
| skin | 0.4219 |
| Cancer Information Service | 0.379239 |
| Primary lymphedema | 0.49612 |
| lymph | 0.792134 |
| body tissues | 0.403337 |
| larger lymph vessels | 0.508148 |
| Stage III lymphedema | 0.489621 |
| National Cancer Institute | 0.439823 |
| arm | 0.413813 |
| lymphedema therapist | 0.534874 |
| Palliative Care Editorial | 0.381473 |
| lymph vessels | 0.714976 |
| limb | 0.427251 |
| lymphedema | 0.932301 |
| certified lymphedema therapist | 0.527418 |
| breast cancer | 0.483638 |
| Care Editorial Board | 0.382648 |
| pressure garment | 0.387805 |
| lymphedema increases | 0.491902 |
| swollen limb | 0.388807 |
| lymph fluid | 0.457795 |
| cancer information summaries | 0.378678 |
| comprehensive cancer information | 0.377712 |
| cancer | 0.547119 |
|
CLICK HERE |
| 1548 |
National Cancer Institute |
Html |
en |
Breast Cancer Screening (PDQ®)–Patient Version |
Mammogram, clinical breast exam (CBE), and MRI (magnetic resonance imaging) tests are used to screen for breast cancer. Learn about this and other tests that have been studied to detect or screen for breast cancer in this expert-reviewed summary. |
| cancer screening methods | 0.42533 |
| fast-growing breast cancer | 0.440825 |
| ongoing clinical trials | 0.389452 |
| following PDQ summaries | 0.382952 |
| PDQ cancer information | 0.474492 |
| following PDQ summary | 0.39258 |
| breast fluid | 0.391775 |
| common screening test | 0.39988 |
| routine breast cancer | 0.436027 |
| clinical trials | 0.527662 |
| cancer information summary | 0.430839 |
| breast tissue sampling | 0.438767 |
| breast cancer prevention | 0.479726 |
| test results | 0.400913 |
| test | 0.410305 |
| Yearly MRI screening | 0.382239 |
| NCI PDQ cancer | 0.406053 |
| women | 0.476763 |
| PDQ Screening | 0.392324 |
| stage breast cancer | 0.437499 |
| screening tests | 0.377685 |
| breast cancer diagnosis | 0.443317 |
| clinical breast exams | 0.420114 |
| regular breast | 0.389266 |
| Cancer Information Service | 0.377203 |
|
| breast cancers | 0.414043 |
| denser breast tissue | 0.419753 |
| breast duct | 0.396464 |
| breast tissue | 0.495937 |
| Prevention Editorial Board | 0.379673 |
| annual screening mammogram | 0.410065 |
| National Cancer Institute | 0.431327 |
| Cancer Screening Overview | 0.412144 |
| breast cancer benefit | 0.435864 |
| breast biopsy result | 0.412172 |
| lymph vessels | 0.375923 |
| breast tumors | 0.395991 |
| breast cancer screening | 0.602061 |
| Cancer screening trials | 0.429799 |
| clinical breast exam | 0.420394 |
| breast cancer | 0.970368 |
| clinical breast | 0.421091 |
| dense breast tissue | 0.418481 |
| PDQ summary | 0.443066 |
| false-positive screening mammogram | 0.452332 |
| breast self-exams | 0.40904 |
| cancer information summaries | 0.380757 |
| comprehensive cancer information | 0.380439 |
| screening mammogram | 0.469345 |
|
CLICK HERE |
| 1574 |
National Cancer Institute |
Html |
en |
Parathyroid Cancer Treatment (PDQ®)–Patient Version |
The parathyroid glands are four pea-sized organs found in the neck near the thyroid gland. Find out about risk and genetic factors, symptoms, tests to diagnose, prognosis, staging, and treatment for parathyroid cancer. |
| entire parathyroid gland | 0.322718 |
| body | 0.312231 |
| Parathyroid hormone test | 0.326008 |
| PDQ cancer information | 0.344395 |
| clinical trial search | 0.297288 |
| parathyroid cancer spreads | 0.351955 |
| cancer information summary | 0.316321 |
| clinical trial | 0.381391 |
| parathyroid hormone | 0.446163 |
| patients | 0.279411 |
| treatment clinical trial | 0.267117 |
| NCI PDQ cancer | 0.284168 |
| parathyroid cancer | 0.907418 |
| parathyroid gland | 0.458873 |
| lymph nodes | 0.287148 |
| supportive care | 0.306655 |
| radiation therapy | 0.415255 |
| Recurrent parathyroid cancer | 0.380003 |
| Treatment Editorial Board | 0.27063 |
| metastatic parathyroid cancer | 0.402384 |
| general cancer information | 0.273517 |
| treatment | 0.412907 |
| Parathyroid Cancer Home | 0.340383 |
| new cancer treatments | 0.272069 |
|
| benign parathyroid adenoma | 0.327035 |
| NCI-supported cancer | 0.273639 |
| cancer cells | 0.359072 |
| standard treatment | 0.270825 |
| parathyroid cancer look | 0.361006 |
| parathyroid adenoma | 0.339034 |
| Cancer Information Service | 0.274336 |
| treatment clinical trials | 0.292746 |
| National Cancer Institute | 0.358229 |
| Parathyroid Cancer Treatment | 0.357344 |
| new treatment | 0.296569 |
| calcium | 0.286368 |
| clinical trials | 0.583365 |
| radioactive substance | 0.27332 |
| Cancer Care page | 0.26586 |
| overactive parathyroid gland | 0.335807 |
| Blood. The cancer | 0.269699 |
| blood | 0.359167 |
| cancer research process | 0.266446 |
| cancer clinical trials | 0.322533 |
| tumor | 0.275377 |
| cancer information summaries | 0.272885 |
| comprehensive cancer information | 0.272952 |
| parathyroid cancer signs | 0.373584 |
|
CLICK HERE |
| 1589 |
National Cancer Institute |
Html |
en |
Adrenocortical Carcinoma Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of adrenocortical carcinoma. |
| treatment | 0.550891 |
| malignant tumor cells | 0.393623 |
| cancer treatment | 0.339234 |
| NCI-supported cancer | 0.325244 |
| cancer cells | 0.380323 |
| Adrenocortical Carcinoma Home | 0.328751 |
| adrenal cortex | 0.482225 |
| body | 0.41124 |
| adrenocortical carcinoma spreads | 0.336583 |
| PDQ cancer information | 0.400868 |
| adrenal medulla | 0.329784 |
| clinical trial search | 0.399161 |
| treatment clinical trials | 0.346018 |
| affected adrenal gland | 0.313913 |
| National Cancer Institute | 0.418105 |
| clinical trials | 0.816364 |
| adrenal gland | 0.62258 |
| High blood pressure | 0.300595 |
| Adrenal gland cells | 0.329473 |
| normal cells | 0.306099 |
| cancer information summary | 0.36038 |
| clinical trial | 0.576848 |
| Adrenocortical Carcinoma Treatment | 0.355819 |
|
| new treatment | 0.426441 |
| nonfunctioning adrenocortical tumor | 0.334163 |
| detailed pictures | 0.31402 |
| patients | 0.305698 |
| adrenocortical carcinoma | 0.949806 |
| Recurrent adrenocortical carcinoma | 0.379499 |
| adrenocortical carcinoma cells | 0.349105 |
| adrenal glands | 0.394752 |
| blood | 0.322073 |
| nuclear magnetic resonance | 0.302225 |
| PDQ summary | 0.318647 |
| treatment clinical trial | 0.305174 |
| NCI PDQ cancer | 0.312561 |
| Treatment Option Overview | 0.314325 |
| cancer clinical trials | 0.41336 |
| lymph nodes | 0.306574 |
| radiation therapy | 0.311431 |
| Treatment Editorial Board | 0.302427 |
| cancer | 0.760261 |
| information | 0.413368 |
| standard treatment | 0.301619 |
| adrenocortical carcinoma depend | 0.345997 |
| positron emission tomography | 0.305618 |
|
CLICK HERE |
| 1669 |
National Cancer Institute |
Html |
en |
Childhood Craniopharyngioma Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of childhood craniopharyngioma |
| evidence | 0.541909 |
| subtotal resection | 0.652496 |
| intensity-modulated photon therapy | 0.593647 |
| Aylwin et al. | 0.579904 |
| Merchant TE | 0.567828 |
| radiation therapy section | 0.596714 |
| PDQ cancer information | 0.54907 |
| Conventional radiation therapy | 0.591705 |
| Tumors Treatment Overview | 0.55265 |
| radiation dose | 0.548781 |
| Int J Radiat | 0.614894 |
| photon radiation therapy | 0.573627 |
| craniopharyngiomas | 0.555197 |
| cancer information summary | 0.541422 |
| Radiat Oncol Biol | 0.7952 |
| irradiated craniopharyngioma | 0.570882 |
| standard fractionated radiation | 0.630603 |
| Tan et al. | 0.575816 |
| conformal radiation treatments | 0.560832 |
| proton therapy | 0.60593 |
| tumor control | 0.588032 |
| common solid tumor | 0.565687 |
| recurrent cystic tumor | 0.550194 |
| radiation therapy | 0.986329 |
| Morisako et al. | 0.5808 |
|
| spare normal tissue | 0.555535 |
| Neurosurg Focus | 0.546254 |
| et al. | 0.839112 |
| complete resection | 0.561879 |
| magnetic resonance imaging | 0.576707 |
| newer radiation technologies | 0.623865 |
| gross-total resection | 0.656285 |
| brain tumor treatment | 0.599377 |
| residual craniopharyngioma | 0.590756 |
| pediatric craniopharyngioma | 0.701375 |
| stereotactic radiation therapy | 0.599058 |
| PUBMED Abstract | 0.577489 |
| craniopharyngioma cyst growth | 0.621968 |
| childhood craniopharyngioma | 0.72734 |
| Abstract | 0.609429 |
| external-beam radiation therapy | 0.569508 |
| pediatric brain tumors | 0.558017 |
| Sterkenburg et al. | 0.578437 |
| Oncol Biol Phys | 0.807866 |
| Neurosurg Pediatr | 0.63126 |
| recurrent craniopharyngioma | 0.572364 |
| papillary craniopharyngioma | 0.570471 |
| tumor | 0.617686 |
| craniopharyngioma | 0.809351 |
|
CLICK HERE |
| 1720 |
National Cancer Institute |
Html |
en |
Vitamin D and Cancer Prevention |
A fact sheet that summarizes the results of studies on vitamin D and cancer prevention. It includes information about dietary recommendations for vitamin D. |
| Vitamin D2 | 0.702012 |
| vitamin D intake | 0.693686 |
| vitamin D toxicity | 0.68752 |
| vitamin D analogs | 0.666953 |
| Vitamin D. IARC | 0.695151 |
| true vitamin | 0.68097 |
| cancer cell growth | 0.487686 |
| vitamin D. Cancer | 0.718314 |
| colorectal cancer risk | 0.525733 |
| vitamin D receptor | 0.666091 |
| blood levels | 0.512913 |
| Dietary Reference Intakes | 0.609551 |
| Vitamin D. Vitamin | 0.928771 |
| high vitamin | 0.694198 |
| additional vitamin | 0.676051 |
| body use calcium | 0.477006 |
| reduced risk | 0.467625 |
| vitamin D supplements | 0.744471 |
| colorectal cancer | 0.645145 |
| Review Dietary Reference | 0.469981 |
| IARC Working Group | 0.527229 |
| National Academies Press | 0.491383 |
| higher blood levels | 0.477109 |
| adequate vitamin | 0.691809 |
| vitamin | 0.965047 |
|
| clinical cancer research | 0.487804 |
| vitamin D levels | 0.742304 |
| calcium levels | 0.481333 |
| Vitamin D deficiency | 0.717219 |
| Cancer Epidemiology | 0.476212 |
| pre-diagnostic circulating vitamin | 0.676944 |
| vitamin D. Excessive | 0.718069 |
| Vitamin D/Calcium Polyp | 0.693854 |
| Muñoz A. Vitamin | 0.683479 |
| dietary vitamin | 0.716868 |
| dietary supplements | 0.510452 |
| National Cancer Institute | 0.502108 |
| average dietary intakes | 0.505042 |
| lower cancer incidence | 0.486263 |
| high intakes | 0.478398 |
| sunlight exposure | 0.498415 |
| Vitamin D. Washington | 0.692063 |
| vitamin D status | 0.736439 |
| higher intakes | 0.472172 |
| prostate cancer | 0.477824 |
| vitamin D3 | 0.72244 |
| et al | 0.609442 |
| high blood levels | 0.479072 |
| vitamin D supplementation | 0.707317 |
|
CLICK HERE |
| 15646 |
National Cancer Institute |
Html |
en |
Grants Management Contacts |
null |
| LIPSCOMB UNIVERSITY UTTER | 0.614715 |
| UNIVERSITY HEALTH SCIENCES | 0.625816 |
| MEDICAL CENTER WALTERS | 0.616396 |
| STATE UNIVERSITY PRITCHARD | 0.643659 |
| HOWARD UNIVERSITY KEARSE | 0.605096 |
| STATE UNIVERSITY COFIE | 0.614592 |
| MEDICAL CENTER | 0.875732 |
| BROWN UNIVERSITY KEARSE | 0.615759 |
| CAROLINA STATE UNIVERSITY | 0.619853 |
| STATE UNIVERSITY SALO | 0.669411 |
| STATE UNIVERSITY KNOWLES | 0.615594 |
| STATE UNIVERSITY KEARSE | 0.653523 |
| UNIVERSITY HEALTH | 0.637053 |
| STATE UNIVERSITY MONTES | 0.717388 |
| AMERICAN UNIVERSITY SOWELL | 0.638565 |
| ATLANTIC UNIVERSITY KEARSE | 0.609604 |
| STATE UNIVERSITY MEININGER | 0.613395 |
| RESEARCH INSTITUTE | 0.777493 |
| ALABAMA STATE UNIVERSITY | 0.62296 |
| BAYLOR UNIVERSITY PRITCHARD | 0.613283 |
| UNIVERSITY CHICAGO NGUYEN | 0.608201 |
| STATE UNIVERSITY HICKMAN | 0.625736 |
| MCGILL UNIVERSITY UTTER | 0.611917 |
| STATE UNIVERSITY MITCHELL | 0.672133 |
| STATE UNIVERSITY NGUYEN | 0.639382 |
|
| RESERVE UNIVERSITY KEARSE | 0.613085 |
| cancer research | 0.608564 |
| UNIVERSITY MEDICAL CAMPUS | 0.61532 |
| CHICAGO STATE UNIVERSITY | 0.608015 |
| DUQUESNE UNIVERSITY WALTERS | 0.608895 |
| STATE UNIVERSITY | 0.98856 |
| STATE UNIVERSITY WONG | 0.676901 |
| LINDA UNIVERSITY UTTER | 0.613669 |
| MEDICAL CENTER MONTES | 0.63558 |
| MEDICAL UNIVERSITY SOWELL | 0.63184 |
| UNIVERSITY HEALTH CTR | 0.621136 |
| ARIZONA UNIVERSITY MONTES | 0.636738 |
| CALIFORNIA STATE UNIVERSITY | 0.645138 |
| UNIVERSITY WALTERS | 0.616172 |
| UNIVERSITY KEARSE | 0.654785 |
| RESEARCH INSTITUTE MONTES | 0.613304 |
| AMERICAN UNIVERSITY MONTES | 0.657637 |
| STATE UNIVERSITY SACRAMENTO | 0.604248 |
| STATE UNIVERSITY REIS | 0.609221 |
| CLARKSON UNIVERSITY MONTES | 0.653016 |
| FLORIDA STATE UNIVERSITY | 0.608756 |
| STATE UNIVERSITY UTTER | 0.65066 |
| STATE UNIVERSITY BAILEY | 0.715208 |
| UNIVERSITY MEDICAL CENTER | 0.735227 |
|
CLICK HERE |
| 15907 |
National Cancer Institute |
Html |
es |
Laetrilo (amigdalina) (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos sobre el uso del laetrilo (amigdalina) como tratamiento para personas con cáncer. |
| siguientes teorÃas | 0.410914 |
| suficiente información | 0.405414 |
| Centro Nacional | 0.412476 |
| Phaseolus lunatus | 0.410368 |
| New Hampshire Avenue | 0.408624 |
| Drug Administration | 0.405353 |
| NCI Best Case | 0.416678 |
| fase i | 0.407749 |
| datos bibliográficos pubmed | 0.409348 |
| largo plazo | 0.408034 |
| siguientes preguntas | 0.406283 |
| vitamina b17 | 0.411219 |
| cuáles tipos | 0.408099 |
| vitamina c | 0.408062 |
| vitamina a | 0.409071 |
| siguientes riesgos | 0.407854 |
| seguro médico | 0.405074 |
| Instituto Nacional | 0.512438 |
|
| Salud Complementaria | 0.418716 |
| Visuals Online | 0.406445 |
| siguientes resultados | 0.443523 |
| complementarias revisa | 0.408971 |
| Physician Data Query | 0.437362 |
| siguientes causas | 0.409284 |
| Estados Unidos | 0.980672 |
| enzimas pancreáticas | 0.42962 |
| Corte Suprema | 0.408891 |
| libre uso | 0.407165 |
| determinadas frutas | 0.407416 |
| página manejo | 0.406016 |
| ¿El tratamiento | 0.415719 |
| ¿Los beneficios | 0.405473 |
| juntos cam | 0.405199 |
| Series Program | 0.405225 |
| medicina complementaria | 0.651404 |
|
CLICK HERE |
| 16184 |
National Cancer Institute |
Html |
es |
Manejo de costos y de información médica |
Las personas con cáncer y sus familias pueden enfrentarse a mayores retos económicos. El tratamiento de cáncer puede ser muy caro, aun cuando se tenga seguro. Aprenda cómo mantener la cuenta de tratamientos y de pruebas, de formularios y cobros, y más. |
| cuáles tratamientos | 0.380156 |
| Busque programas | 0.344502 |
| información médica clave. | 0.356222 |
| médico muestras | 0.355273 |
| expediente personal | 0.405493 |
| Health Information Management | 0.361343 |
| importante cuál sistema | 0.365142 |
|
| mayores retos | 0.375386 |
| Busque asistencia | 0.353171 |
| Busque formas | 0.327721 |
| Sociedad Americana | 0.349375 |
| busque ayuda | 0.333405 |
| seguro médico | 0.91222 |
| mano. revise cuáles | 0.413273 |
|
CLICK HERE |
| 16717 |
National Cancer Institute |
Html |
en |
Cancer Clinical Trials at the National Institutes of Health Clinical Center |
Information about cancer clinical trials at the NIH Clinical Center in Bethesda, Maryland. |
| cancer treatment | 0.534356 |
| better understanding | 0.369317 |
| clinical program | 0.414778 |
| eligibility criteria | 0.37194 |
| health insurance | 0.371915 |
| novel cancer treatment | 0.457878 |
| International patients | 0.371646 |
| health care provider | 0.502194 |
| clinical trial experience | 0.462664 |
| clinical teams | 0.407146 |
| NIH physicians | 0.420773 |
| Patients page | 0.377331 |
| NCI clinic | 0.401655 |
| open trials | 0.377021 |
| in-house cancer center | 0.477433 |
| Patient Self-Referral Form | 0.427003 |
| unique hospital | 0.366285 |
| clinical trials | 0.623234 |
| treatment services | 0.380122 |
| health care providers | 0.57596 |
| approach fosters interaction | 0.418119 |
| National Institutes | 0.375152 |
| clinical trial | 0.527278 |
| contact information | 0.370247 |
| CCR clinical trials | 0.482065 |
|
| patients | 0.409802 |
| cancer patients | 0.399962 |
| standard treatment options | 0.440025 |
| trial’s eligibility | 0.38116 |
| related research | 0.378808 |
| patient care units | 0.440886 |
| United States | 0.412623 |
| largest hospital | 0.37768 |
| cancer research | 0.528759 |
| NIH Clinical Center | 0.949828 |
| National Cancer Institute | 0.460111 |
| NCI research team | 0.453825 |
| Clinical Research Referral | 0.467688 |
| Developmental Therapeutics Clinic | 0.698646 |
| advanced cancer | 0.386466 |
| trial information | 0.38805 |
| new treatments | 0.372193 |
| NCI principal investigator | 0.437174 |
| patient treatment plans | 0.430619 |
| compassionate doctors | 0.368527 |
| care specialists | 0.389607 |
| medical care | 0.431584 |
| scientific resources | 0.368533 |
| trial summary | 0.38584 |
|
CLICK HERE |